Concur: a Randomized, Placebo-Controlled Phase 3 Study of Regorafenib (Reg) Monotherapy in Asian Patients with Previously Treated Metastatic Colorectal Cancer (Mcrc)
T.W. Kim1, R. Xu2, T.C.C. Yau3, B. Ma4, H. Pan5, J. Xu6, Y. Bai7, Y. Chi8, L. Wang9, K. Yeh10, F. Bi11, Y. Cheng12, A.T. Le13, J. Lin14, T. Liu15, D. Ma16, J. Shapiro17, J. Kalmus18, S. Qin19, J. Li20
1Division of Hematology/oncology, University of Ulsan College of Medicine Asan Medical Center, Songpa-gu, KOREA
2Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
3Medical Oncolgy, Queen Mary Hospital University of Hong Kong, Hong Kong, CHINA
4Medical Oncology, "Prince of Wales Hospital Chinese University of Hong Kong", Hong Kong, CHINA
5Medical Oncology, "Sir Run Run Shaw Hospital Medical School of Zhejiang University, Hangzhou, CHINA
6Medical Oncology, Beijing 307 PLA Hospital Cancer Centre, Beijing, CHINA
7Medical Oncology, The 3rd Affiliated Hospital of Harbin Medical University, Harbin, CHINA
8Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, CHINA
9Medical Oncology, Shanghai First People's Hospital Shanghai Jiaotong University, Shanghai, CHINA
10Medical Oncology, National Taiwan University Hospital, Taipei, TAIWAN
11Medical Oncology, "West China Hospital Sichuan University", Chengdu, CHINA
12Medical Oncology, Jilin Provincial Tumor Hospital, Changchun, CHINA
14Colon and Rectum Surgery, Taipei Veteran General Hospital, Taipei, TAIWAN
15Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
16Medical Oncology, Guangdong General Hospital, Guangdong, CHINA
17Global Biostatistics, "Bayer HealthCare Pharmaceuticals ", Whippany, NJ, USA
18Global Clinical Development, Bayer Pharma AG, Berlin, Germany
19Medical Oncology, Cancer Center of Nanjing Bayi Hospital, Nanjing, CHINA
20Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China